Evidence map›Paper›PMID 18755252›Full record

ArticleBrain research bulletin2008

Activation of cholinergic receptors blocks non-adrenergic non-cholinergic contractions in the rat urinary bladder.

H Henry Lai, Christopher P Smith, Alvaro Munoz, Timothy B Boone, Gyula P Szigeti, George T Somogyi

Open access · greenAbstract read
In one paragraph

Article in Brain research bulletin, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Concomitant alteration in number and affinity of PInternational urology and nephrology · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

H Henry LaiNeurology Laboratory, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA.
Christopher P Smith
Alvaro Munoz
Timothy B Boone
Gyula P Szigeti
George T Somogyi
Baylor College of Medicine · USMethodist Hospital · USUniversity of Debrecen · HU

Funding

Nicotinic-Purinergic Modulation of Bladder ContractionR01DK069988 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI SOMOGYI, GEORGE T · 2005 to 2009
$1.5M
NIDDK NIH HHS R01 DK069988
6 · The paper itself

Abstract

In the present study, the plasticity of the non-adrenergic non-cholinergic (NANC) response was investigated. Isolated rat bladder strips were electrically stimulated and the evoked contractions were isometrically recorded. The NANC part of the contractions were unmasked by applying 500 nM 4-DAMP, a potent muscarinic antagonist. Treatment of the bladder strips with 10 microM carbachol (a cholinergic agonist) increased the muscle tone but did not alter the neurally evoked contractions. However, carbachol decreased: (1) the NANC response from 74.6% to 33.3% of control and (2) the purinergic contractile response to alpha,beta-methylene ATP (alpha,beta-mATP) (10 microM) from 97.0% to 43.4% (p<0.05). Treatment with the cholinesterase inhibitor eserine (10 microM) also significantly decreased the NANC response to 21.1% (p<0.0001). The purinergic receptor antagonist suramin (100 microM) did not affect the neurally evoked contractions, however; subsequent addition of 4-DAMP decreased the contractions to 31%. Activation of the smooth muscle cholinergic receptors (with carbachol or eserine) and purinergic receptors (with alpha,beta-mATP) decreased the NANC contractions and the direct contractile response to alpha,beta-mATP. When the electrically evoked contractions were facilitated by the L-type Ca2+ channel activator, Bay-K 8644 the subsequent application of 4-DAMP did not unmask inhibited NANC contractions. We conclude that activation of muscarinic receptors by cholinergic agonist, carbachol or by endogenous acetylcholine (ACh) induce a cascade of events that leads to diminished purinergic response and consequently an inhibition of the bladder NANC response.

Indexed as

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAdenosine TriphosphateAnimalsAntineoplastic AgentsAtropineCalcium Channel AgonistsCarbacholCholinergic AgonistsCholinesterase InhibitorsElectric StimulationFemaleIn Vitro TechniquesMuscarinic AntagonistsMuscle ContractionMuscle RelaxationMuscle, Smooth3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester4-diphenylacetoxy-1,1-dimethylpiperidiniumAdenosine Triphosphatealpha,beta-methyleneadenosine 5'-triphosphateAntineoplastic AgentsAtropineCalcium Channel AgonistsCarbacholCholinergic AgonistsCholinesterase InhibitorsMuscarinic AntagonistsPhysostigminePiperidinesReceptors, CholinergicSuramin

Identifiers

PMID18755252
PMCPMC2724651
OpenAlexW1964910170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.